Alex Lobo | Stern, Investor Relations |
Kevin Boyle | Chief Executive Officer |
Drew Deniger | Vice President, Research and Development |
Mike Wong | Vice President, Finance |
Nick Abbott | Wells Fargo |
Prakhar Agrawal | Cantor Fitzgerald |
Thomas Flaten | Lake Street Capital Markets |
Good day and thank you for standing by. Welcome to Alaunos Therapeutics First Quarter 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions] I'd now like to hand the call over to your speaker today, Mr. Alex Lobo, Investor Relations.